Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Zanamivir results presented at ICAAC; two more regulatory filings announced

Sep. 25, 1998

In vitro and in vivo activity of S-34109 against Chlamydia and MRSA

Sep. 25, 1998

IB-643 more effective than AmB in treating systemic murine candidosis

Sep. 25, 1998

Profile of activity of new antifungal antibiotic presented by Fujisawa at ICAAC

Sep. 25, 1998

Administration of multiple high doses of S-4661 does not affect safety, pharmacokinetics

Sep. 25, 1998

KRM-1648 combinations show strong, rapid and long-lasting antimycobacterial activity

Sep. 25, 1998

HSR-903 shows excellent antibacterial activity, intracellular penetration in in vitro studies

Sep. 25, 1998

Novel cephems from Meiji Seika active against resistant bacterial strains

Sep. 25, 1998

Warner-Lambert team prepares inhibitors of bacterial signal transduction

Sep. 25, 1998

Broad-spectrum antiviral agents related to phosphonoformic acid patented by Astra

Sep. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.